SPACInsider Logo
Eric Rosenfeld Files for SPAC #6 with Allegro Merger Corp.
by Kristi Marvin on 2018-05-30 at 1:00am

Crescendo is Putting the Band Back Together.  Again!

Crescendo Partners’ Eric Rosenfeld, filed for a $130 million IPO late Tuesday, making Allegro Merger Corp., Rosenfeld’s sixth consecutive SPAC. In addition to an obsessive penchant for musical-term branding, the Allegro team and board seem to have a penchant for each other as well, since all have worked together (with the exception of board member Robert Deluce) on one or more of Rosenfeld’s five prior SPACs.  It’s a reunion tour roadshow for sure, but let’s get to the details.

Summary terms include:
  • Sector Focus: General / Broad
  • $10.00 unit comprised of one share of common stock, one right and one full warrant
  • Each right entitles the holder to receive one-twentieth (1/20) of one share 
  • 100% held in trust ($10.00 per share)
  • 21 months to complete an acquisition 
  • Warrant redemption price: $18.00
  • Redemption rights:  limitation of 20% of the shares sold in the IPO
  • Founders and Cantor Fitzgerald (the Underwriter) to purchase 372,500 private placement units at $10.00 to bring the trust to 100% (Founders – 322,500 units / Cantor – 50,000 units)
  • Underwriter fees: 2.0% + 3.5% deferred fee.  Cantor Fitzgerald is sole book-runner.

The Rights term is what stands out immediately. 1/20th of one share is the first to deviate from the standard 1/10th of one share. While on the face of it this might seem like a negative, Allegro does balance this by offering a full warrant and a 21 month time period to complete their business combination.  Additionally, the limit for shareholders wishing to redeem is at 20% of the shares sold in the offering.  More recent SPACs have had limits of 15%.

As for the five prior SPACs that the Crescendo team have completed, I’ve provided a summary below.

NameIPO
Date
Unit
Price
Gross
Proceeds
(mms)
AcquisitionAcquisition
Symbol
Acquisition
Current
Share Price
Arpeggio Acquisition CorporationJune-04$6.00$40.8Hill InternationalHIL$5.60
Rhapsody Acquisition CorporationOct-06$8.00$41.4Primoris ServicesPRIM$26.27
Trio Merger Corp.June-11$10.00$69.0SAExplorationSAEX$1.41
Quartet Merger Corp. Nov-13$10.00$96.6Pangaea LogisticsPANL$3.39
Harmony Merger Corp. Mar-15$10.00$115.0NextDecade NEXT$6.35

Primoris is a hit, but the majority are misses.

Past performance may not be indicative of future results…”  Let’s hope that famous warning disclosure at the end of every performance report rings true here.  On the whole, this deal looks like it might need some sweetening. Perhaps more at-risk capital from management to over-fund the trust and/or reverting the rights terms to 1/10th of one share will give investors additional comfort.

Lastly, Issuer’s Counsel and Underwriter’s Counsel are Graubard Miller and Ellenoff Grossman & Schole LLP,  respectively.

Recent Posts
by Nicholas Alan Clayton on 2023-01-30 at 12:07am

Prime Impact I (NYSE:PIAI) has entered into a definitive agreement to combine with auto insurance firm Cheche at an enterprise value of $841 million, or about 2.3x its 2022 revenue. Beijing-based Cheche provides a digital insurance platform for car owners in China with about 34 million vehicles covered. The combined company is expected to trade...

by Marlena Haddad on 2023-01-30 at 11:42am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Hambro Perks eyes merger with Biotech Istesso, Rocket Lab launches first vehicle from U.S. soil, and Alliance Entertainment signs licensing agreement with The Walt Disney Company Hambro Perks SPAC Eyes Merger With Biotech...

by Marlena Haddad on 2023-01-30 at 10:15am

Pono Capital Corp. (NASDAQ:PONO) disclosed in an 8-K filing this morning that its shareholders approved its combination with air mobility company AERWINS at a special meeting held on Friday, January 27. Holders of 12,412,861 common shares were present at the meeting and the deal was approved with 11,218,712 shares in favor of the transaction. The filing did not...

by Nicholas Alan Clayton on 2023-01-30 at 9:07am

European Biotech (NASDAQ:EBAC) announced in an 8-K this morning that it has increased its PIPE by $7.8 million and added $7 million to the convertible loans attached to the combination with biotech firm Oculis. The new PIPE cash comes at $10 per share and joins $63.3 million in existing PIPE financing for a total of...

by Nicholas Alan Clayton on 2023-01-30 at 7:17am

DHC Acquisition Corp (NASDAQ:DHCA) announced that it is formally terminating its combination with conservative banking venture GloriFi. This was essentially a formality because the SPAC already announced in November that GloriFi had begun the process of winding down.  The two sides announced their $1.7 billion combination in July. But, even at the time, public details...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved